These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12637096)

  • 1. Complex formation of sericoside with hydrophilic cyclodextrins: improvement of solubility and skin penetration in topical emulsion based formulations.
    Rode T; Frauen M; Müller BW; Düsing HJ; Schönrock U; Mundt C; Wenck H
    Eur J Pharm Biopharm; 2003 Mar; 55(2):191-8. PubMed ID: 12637096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration of lipid degradation by sericoside of Terminalia sericea roots in Fully differentiated 3T3-L1 cells.
    Mochizuki M; Hasegawa N
    Phytother Res; 2006 Nov; 20(11):1020-1. PubMed ID: 17009207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of ursolic and oleanolic acids' antitumor activity by complexation with hydrophilic cyclodextrins.
    Oprean C; Mioc M; Csányi E; Ambrus R; Bojin F; Tatu C; Cristea M; Ivan A; Danciu C; Dehelean C; Paunescu V; Soica C
    Biomed Pharmacother; 2016 Oct; 83():1095-1104. PubMed ID: 27551755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling the Antibacterial Activity of
    Anokwuru CP; Tankeu S; van Vuuren S; Viljoen A; Ramaite IDI; Taglialatela-Scafati O; Combrinck S
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32823484
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
    Loftsson T; Stefánsson E
    Acta Ophthalmol Scand; 2002 Apr; 80(2):144-50. PubMed ID: 11952479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of camphor/cyclodextrin complexation on the stability of O/W/O multiple emulsions.
    Yu SC; Bochot A; Bas GL; Chéron M; Mahuteau J; Grossiord JL; Seiller M; Duchêne D
    Int J Pharm; 2003 Aug; 261(1-2):1-8. PubMed ID: 12878390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
    Jambhekar S; Casella R; Maher T
    Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct compression tablets containing a series of four beta-cyclodextrin complexes formed by neutralizing an acidic drug.
    Moore E; Bergamo R; Casella R
    Drug Dev Ind Pharm; 2000 Dec; 26(12):1259-70. PubMed ID: 11147126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
    Veiga MD; Ahsan F
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrins in topical drug formulations: theory and practice.
    Loftsson T; Masson M
    Int J Pharm; 2001 Aug; 225(1-2):15-30. PubMed ID: 11489551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
    Echezarreta-López M; Torres-Labandeira JJ; Castiñeiras-Seijo L; Santana-Penín L; Vila-Jato JL
    Eur J Pharm Sci; 2000 Feb; 9(4):381-6. PubMed ID: 10664478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical formulation studies with DEET (N,N-diethyl-3-methylbenzamide) and cyclodextrins.
    Proniuk S; Liederer BM; Dixon SE; Rein JA; Kallen MA; Blanchard J
    J Pharm Sci; 2002 Jan; 91(1):101-10. PubMed ID: 11782901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins.
    Cavalli R; Peira E; Caputo O; Gasco MR
    Int J Pharm; 1999 May; 182(1):59-69. PubMed ID: 10332075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
    Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
    Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of benznidazole:cyclodextrin complexes on the drug bioavailability upon oral administration to rats.
    Leonardi D; Bombardiere ME; Salomon CJ
    Int J Biol Macromol; 2013 Nov; 62():543-8. PubMed ID: 24120966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of sucrose stearate-based nanoemulsions and optimisation through γ-cyclodextrin.
    Klang V; Matsko N; Raupach K; El-Hagin N; Valenta C
    Eur J Pharm Biopharm; 2011 Sep; 79(1):58-67. PubMed ID: 21277976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion Complexes of β and HPβ-Cyclodextrin with α, β Amyrin and In Vitro Anti-Inflammatory Activity.
    da Silva Júnior WF; Bezerra de Menezes DL; de Oliveira LC; Koester LS; Oliveira de Almeida PD; Lima ES; de Azevedo EP; da Veiga Júnior VF; Neves de Lima ÁA
    Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31234312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.